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Summary 1 
A study was conducted to evaluate a natural carbohydrate fraction (NCF) derived from mannan 2 
oligosaccharide in feed on growth performance, intestinal morphology and goblet cell number and 3 
area of male broilers. Dietary treatments included: 1) control diet (antibiotic and NCF free), 2) 4 
NCF at 200g/t, 3) NCF at 400g/t, and 4) NCF 800g/t. Birds were placed into 12 replicate 5 
pens/treatment (5 birds/pen). Body weight and feed intake were recorded weekly to day 42. At this 6 
time a 2.5cm section of jejunum and duodenum were excised post mortem for morphological 7 
analysis.  Birds fed 200g/t and 800g/t NCF were significantly (P<0.01) heavier from day 14 8 
onwards than the control birds. Feed intake was significantly increased for birds fed 200g/t NCF 9 
over the control in weeks 3 and 5 (P<0.05). Diet including 200g/t and 800g/t of NCF significantly 10 
decreased the FCR over the control in the first phase (1-14 days) (P<0.01), in the second phase all 11 
inclusion levels of NCF decreased FCR (P<0.05). NCF had no significant effect on villus height, 12 
villus width, crypt depth or villus to crypt ratio in either duodenum or jejunum. NCF did not 13 
significantly affect goblet cell area or goblet cell number in the duodenum, however in the jejunum 14 
800g/t NCF significantly (P<0.05) increased goblet cell area over the control. In conclusion under 15 
the conditions of this trial NCF showed a positive effect on performance in the starter and grower 16 
phases, and increased goblet cell area in the jejunum, suggesting higher levels of mucin production. 17 
This indicated that the performance benefit of NCF could be age-dependent with younger birds 18 
responding more than the older ones. In the conditions of the poultry research unit, there were no 19 
additional benefits to performance when feeding NCF for a longer period (post 4 weeks), however 20 
it is postulated that birds fed NCF would have greater defence to pathogenic challenge through 21 
increased storage capacity of mucin. 22 
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INTRODUCTION 24 
Over the past few years there has been increased concern about antibiotic resistant bacteria and the 25 
inclusion of antibiotics in animal diets for growth promotion. This led to the ban of a number of 26 
antibiotics growth promoter (Dibner & Richards, 2005). Since the EU ban on using antibiotic as 27 
growth promoters in 2006 (Huff, et al., 2006), there has been an increase in the incidence of 28 
endemic diseases in poultry (Chee, 2008), in addition to reports of slower growth and higher 29 
disease challenges causing significant economic losses (Thomke & Elwinger, 1998) and negative 30 
welfare implications for poultry. In particular the gut health has been affected. Without a healthy 31 
intestinal tract a broiler cannot reach its full performance potential. Due to this there has been a 32 
drive in the market for feed supplements that will improve health and production of poultry but 33 
remain safe for humans. The morphological structure of the gastrointestinal tract (GIT) offers key 34 
information to judge gut health. Longer, thinner villi are considered to indicate that the bird will 35 
have a better ability to absorb nutrients, due to the increased surface area (Gao, et al., 2008). Shorter 36 
villi height (VH) and deeper crypt depth (CD) are associated with decreased digestibility of 37 
nutrients (Zhang, et al., 2005). Deeper CD are considered a negative indication of gut health 38 
because new epithelial cells are produced in the crypts and migrate along the villi to the tip (Gao, 39 
et al., 2008), therefore deeper CD indicates that there is a higher tissue turnover of epithelium cells. 40 
It is thought that the faster turnover of tissue is due to the host’s compensating for villus atrophy 41 
due to inflammation resulting from pathogens and their toxins (Gao, et al., 2008).  42 
Mannan oligosaccharides (MOS) are mannose-based carbohydrates it can be derived from yeast 43 
cell walls and have a prebiotic function (Chee, 2008). MOS has been shown to have a positive 44 
effect on gut heath, by binding to enteropathogens, inhibiting their proliferation and stimulating 45 
specific microbial populations in the GIT (Spring, et al., 2000; Kocher, et al., 2004). This leads to 46 
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increased VH and decreased CD, which may in turn improve nutrient absorption (Santin et al 2001; 47 
Sims, 2004; Mourão et  al., 2006).  Goblet cells are found in the epithelial layer along the villi of 48 
the bird’s GIT. Goblet cells produce and secrete mucin glycoproteins that make up part of the 49 
mucus layer, which protects the intestinal surface against damage by bacterial and environmental 50 
toxins, microorganisms and some coarse dietary components (Santos et al., 2007). Several studies 51 
have also found that feeding MOS increases the number and/or the volume of goblet cells found in 52 
the small intestinal tract (Baurhoo, et al., 2009; Brummer, et al., 2010). It has not only been found 53 
that MOS has increased the number of goblet cells but also their size (Uni and Smirnov, 2006). 54 
Mucin is also thought to be beneficial to developing the innate immune system (Koutsos and Arias, 55 
2006).  56 
Actigen™ (Alltech Inc. Nicholasville, Kentucky, USA), is a specific natural carbohydrate fraction 57 
(NCF) that has been derived from the cell wall of saccharomyces cerevisiae. NCF should contain 58 
a high affinity for the mannose- specific type-1 fimbriae of pathogenic bacteria such as Escherichia 59 
coli. (Ofek,  et al., 1977) and salmonellae (Spring, et al., 2000; Miguel, et al., 2004). The objective 60 
of this study was to evaluate the effect of this specific natural carbohydrate fraction isolated from 61 
yeast cell wall oligosaccharides, on VH, CD and the goblet cell profiles of broilers. 62 
MATERIALS AND METHODS 63 
Two hundred and forty day-old male Ross 308 birds were placed in 48 different pens, each 64 
containing 5 birds and fed 1 of 4 dietary treatments (12 replicates for each treatment). The diets 65 
were randomly allocated to remove any effect of the room environment on the study. The room 66 
temperature was initially adjusted to 32oC and then gradually lowered to reach approximately 21oC 67 
by d 21. Temperature was monitored on a daily basis and light was 23D:1L for the duration of the 68 
experiment. Birds were kept with a stocking density aiming for a 30kg per m2 on day 42. Birds 69 
 4 
 
were provided with ad libitum access to water and feed. Feed was a wheat/soya based mash 70 
containing no enzymes or coccidiostats. The trial lasted 42 days with a 3 phase feeding programme, 71 
starter (1 to 14 d); grower (15 to 28 d) and finisher (29 to 42 d). The basal diet was formulated and 72 
made by Target feeds (Coton, Whitchurch, Shropshire, UK), formulations are shown in table 1. 73 
The dietary treatments were then added to the basal diet. The 4 dietary treatments were; 1) control 74 
diet (antibiotic and NCF free), 2) NCF at 200g per tonne, 3) NCF at 400g per tonne, and 4) NCF 75 
800g per tonne. Weekly and overall feed intake and weight gain was recorded of birds prior to 76 
culling on day 42. At this time a 2.5cm section of jejunum and duodenum were removed and 77 
immediately rinsed with PBS solution. The tissue was then placed in Bouin’s fixative for 8 hours 78 
and then stored in 70% industrial methylated spirits. The tissue samples were then embedded in 79 
paraffin and cut at 8µm using a rotary microtome (Leitz Wetzlar 1512 microtome Leitz, Milton 80 
Keynes, Bucks, UK). The sections were stained with a combination of 1% alcian blue (pH 2.5) and 81 
periodic acid-Schiff’s reagent. The following measurements were taken using a light microscope; 82 
CD, villus height (VH), villus width (VW), villus/crypt ratio (VCR), and goblet cell area and 83 
number of the jejunum. VH was measured as the length between the villus-crypt axis and the tip 84 
of the villus (20 villi per sample, 240 per treatment). 85 
The VW was measured at the midpoint between the villus-crypt axis and the tip of the villus. CD 86 
was measured from the villus-crypt axis to the base of the specific crypt. Goblet cell area was 87 
measured as the “cup” area of the goblet cells (µm2). Two hundred measurements (10 88 
measurements on 20 villi) were made for each intestinal sample. Goblet cell density was 89 
determined as the number of goblet cells per 165µm. Gut morphology was analysis using an 90 
Olympus BX51 microscope fitted with an Olympus DP71 camera (Olympus Microscopy, Essex, 91 
UK) and Cell F software (Olympus Europa GmbH, Hamburg) was used for all measurements. Gut 92 
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morphology measurements and performance data were analysed using SPSS software version 12 93 
for Windows; First the data was analysed for normality. If the data was normally distributed a 1-94 
way ANOVA was used, if the data was not normally distributed a Kruskal-Wallis test was 95 
performed. Treatment means were separated using the Bonferroni’s post hoc test, and statistical 96 
significance was declared at P < 0.05. Institutional and national guidelines for the care and use of 97 
animals were followed and all experimental procedures involving animals were approved by the 98 
Nottingham Trent University College of Science ethical review committee. 99 
RESULTS AND DISCUSSION  100 
The live body weight is presented in table 2. Significant (P<0.01) differences between treatments 101 
were observed for body weight on days 14, 21, 28, 35 and 42, generally 200g/t and 800g/t NCF 102 
increased live weight over the control. Feed intake was significantly increased for birds fed 200g/t 103 
of NCF over the control in weeks 3 and 5 (respectively P = 0.021, P = 0.025, data not shown). The 104 
FCR is presented in table 2, a significant difference was observed for the first and second phase of 105 
feeding. Diet including 200g/t and 800g/t of NCF significantly decreased the FCR over the control 106 
in the first phase (P<0.01), whereas in the second phase all inclusion levels of NCF decreased FCR 107 
(P<0.05). However the FCR seen in week one for the control and 400g/t NCF is abnormally high 108 
for nutritionally complete diets, indicating excessive spillage. 109 
Morphometric measurements from the stained slides are shown in table 3. It was observed that 110 
NCF had no significant effect on VH, VW, CD or VCR in either the jejunum or duodenum.   111 
When looking at the goblet cell number and area in the duodenum  (table 4), it is observed that the 112 
diets including NCF did not significantly affect goblet cell area, goblet cell number per 165μm or 113 
goblet cell measurements as a ratio, however in the jejunum 800g/t NCF significantly (P<0.05) 114 
increased goblet cell area over the control.  115 
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Supplementation of 200g/t and 800g/t of NCF significantly increased weekly bird body weights 116 
compared to the control diet from 14 days, but the inclusion level of 400g/t NCF did not 117 
significantly change body weight from the control. This indicates that there may be two 118 
mechanisms behind the observed response to supplementation; one occurring at the lowest 119 
inclusion and one occurring at the highest inclusion, with apparently antagonist effects at the 120 
middle inclusion level. This contradicts both Reisinger et al. (2012) and Gao et al. (2008) who 121 
found a positive quadratic response in broiler body weight to a yeast derivative and yeast cell 122 
culture respectively. The authors suggest an explanation for these findings is that higher inclusion 123 
levels may be interacting with the immune system causing energy to be partitioned towards the 124 
immune system, rather than supporting growth. Whilst this mechanism may explain the observed 125 
response at 400g/t NCF, it does not support the improved performance at 800g/t NCF.  126 
Increased body weight following supplementation with MOS (such as that observed at 200g and 127 
800g/t in the current study) is often attributed to reduced effects of pathogenic bacteria in the 128 
intestinal tract as the binding of pathogenic bacteria to MOS results in their evacuation from the 129 
intestine with other non-digested feedstuffs (Spring et al., 2000). This may have reduced sloughing 130 
of villi in birds fed MOS thereby contributing to increased performance compared to the control, 131 
due to an increased capacity to absorb nutrients (Sun et al. 2005). When feeding NCF to broilers it 132 
could be postulated that birds will also have longer VH and shorter CD via a similar reduction in 133 
sloughing, because Spring et al. (2000) reported that pathogens with the mannose-specific type-1 134 
fimbriae, such as some strains of Escherichia coli, Salmonella typhimurium and Salmonella 135 
enteritidis, are attracted to mannans, which are reported to be present in NCF (Che, et al., 2012), 136 
and readily bound with them instead of attaching to intestinal epithelial cells (Castillo, et al., 2008). 137 
Therefore these pathogenic bacteria cannot colonise the GIT and release toxins. These bacterium 138 
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and their toxins can cause inflammation that in turn cause atrophy of the epithelial cells of the villi 139 
(Gao, et al., 2008), thus reducing the absorptive function of the gut through shorter VH and deeper 140 
CD (Yason, et al., 1987). If the NCF bind the pathogenic bacteria and reduce the level of these 141 
bacteria in the GIT, there will be less villi damage in the gut therefore improving the gut health of 142 
the bird. To compensate for this atrophy the bird has to increase it’s tissue turn over, and as 143 
epithelial cells are produced in the crypts and migrate along the villi to the tip, it is thought that the 144 
higher turnover in the crypt cell cause it to become deeper (Gao, et al., 2008). Therefore shallower 145 
CD are considered a good indicator of gut health. MOS are also thought to increase the number of 146 
beneficial bacteria in the gut.  147 
Morphometric analysis at 6 weeks revealed that NCF had no significant effect on the gut 148 
morphology of the birds at this time point. A possible reason why no effect was evident in the gut 149 
morphology and performance of birds fed NCF at 6 weeks, may be due to the birds not being 150 
challenged with pathogenic microbes at this point. This trial supports the VH findings of White, et 151 
al. (2002) in pigs and Yitbarek et al. (2012) and Sohail et al. (2012) in broilers when feeding MOS. 152 
However, Iji et al. (2001) and Zhang et al. (2005) found that birds fed yeast cell wall fractions had 153 
longer VH than control birds at 21 days. Similarly, Baurhoo et al. (2007) measured VH and found 154 
that MOS improved VH at 28 days but not at 42 days. A similar, early age response may have 155 
occurred in this present study, but as histological measures were not taken at 21 or 28 days this 156 
cannot be verified. 157 
When looking at CD, Zhang et al. (2005), Yitbarek et al. (2012) and Sohail et al. (2012) found 158 
feeding MOS had no effect on CD in birds, which was also shown in this study. Santin et al. (2001) 159 
also saw no effect of MOS at 42 days, however, decreased CD was seen when feeding MOS at 7 160 
days. In addition, this present study found no effect on VCR, which can be used as a marker of 161 
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overall intestinal health as it takes into account both CD and VH. This trial included a total of 240 162 
measures for each treatment, which is a considerable amount and therefore it should be noted that 163 
taking more measures to try and reduce associated error would have major time and cost 164 
implications. The inherent variability both in this study and other studies suggests that measuring 165 
VH and CD may not be an optimal approach to quantifying gut health.  166 
This study showed that the greatest benefit of NCF to FCR occurred at the beginning of the trial, 167 
indicating there may be an optimum time for the supplementation of NCF to increase the efficiency 168 
of the birds. This may be due to the fact that the gut microflora of younger birds is more transient 169 
in nature and less established than in older birds and therefore more susceptible to colonisation by 170 
pathogenic bacteria. Therefore prebiotic intervention may shorten the time required to create a 171 
beneficial microflora population if it is offered early in life. However, similar studies have found 172 
variable early performance effects (Zhang et al., 2005; Iji et al., 2001; Sun et al., 2005; Midilli et 173 
al., 2008). In this study it was generally shown that NCF improved FCR over the starter and grower 174 
feeding phases. This suggests that the inclusion of NCF in the diet at both the starter and grower 175 
phase, increases the efficiency of the birds. This concurs with Zhang et al. (2005), however, other 176 
studies have shown no early response (Iji et al., 2001; Sun et al., 2005; Midilli et al., 2008). 177 
It could be hypothesised that the improvements observed in FCR early on in the study when feeding 178 
NCF may have been due to an increase in absorptive area, due to an increase in lactobacilli and 179 
bifidobacterial populations and a reduction in pathogenic bacteria. This  has been seen in other 180 
studies where improvements in gut morphology is associated with increased lactobacilli and 181 
bifidobacterial populations (Baurhoo, et al., 2009). However, improvements in gut health were not 182 
observed in this present study as histological measurements were only recorded at 6 weeks, when 183 
the microflora is already established with a population of beneficial bacteria. This means that birds 184 
 9 
 
on all treatment groups were not under any challenge and it was seen that NCF had no effect on 185 
the performance in the last phase of the trial, which is consistent with the histological measurements 186 
at 6 weeks. 187 
There is no consensus on whether an increase in goblet cell numbers and area is considered an 188 
improvement in bird health. Increasing the number and area of goblet cells is thought to increases 189 
the volume of mucin stored in the GIT and possibly its production (Brümmer et al., 2010). Mucin 190 
is essential for a number of brush border processes, including facilitating absorption of nutrients, 191 
containing enzymes, lubrication and decreasing the binding and colonisation of pathogenic bacteria 192 
to the intestine (Blomberg et al., 1993; Smirnov et al., 2004). Therefore an increase in the level of 193 
mucin could have a beneficial effect on the first line of defence of the immune system (Baurhoo et 194 
al., 2009) and the absorptive function of the gut. Contrarily, overproduction of mucin may result 195 
in an negative effect, by increasing the mucus thickness on the GIT wall to a level that might 196 
negatively affect the ability of nutrients to pass through to the gut epithelial to be absorbed 197 
(Smirnov et al., 2004; Brummer, et al., 2010).  198 
In this study, the number and area of goblet cells in the duodenum and jejunum were not affected 199 
by the supplementation of NCF at 42 days. This would suggest that NCF has no effect on the mucin 200 
profile of broilers in the duodenum in this study. This absence of response was also reported by 201 
Castillo et al. (2008) and Yitbarek et al. (2012), however Baurhoo et al. (2007; 2009); Chee et al. 202 
(2010); Morales-lopez et al. (2010) and Muthusamy et al. (2012) all found goblet cell numbers 203 
were increased by yeast cell wall product supplementation. In the jejunum it was seen that NCF 204 
increases the area of goblet cells and there was a trend for increasing goblet cell area per 165 μm 205 
of villi, suggesting that NCF at 800g/t affects the mucin profile of broilers in the jejunum. Published 206 
data on goblet cell area is very limited: Brummer et al. (2010) also found that the area of goblet 207 
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cells increased with supplementation of MOS. Insight into the mechanisms behind this goblet cell 208 
response would be highly beneficial to understanding the effect of NFC supplementation on gut 209 
health.  210 
An increase in goblet cell area is thought to show that the storage capacity of the goblet cell for 211 
mucin has increased (Smirnov et al., 2005). The increase in mucin storage may suggest that the 212 
bird is more capable of forming a protective layer on the villi, thereby helping protect the intestine 213 
from damage caused by enteropathogens if there was a challenge from pathogenic bacteria 214 
(Smirnov et al., 2006; Brümmer et al., 2010). One suggested mechanism of MOS on mucin 215 
production is through changing the gene expression of key genes through direct crosstalk between 216 
beneficial intestinal microbes and goblet cells, (Mack et al., 1999; Freitas et al., 2003; Smirnov et 217 
al., 2005 Uni and Smirnov 2006; Chee, 2008). The effects of NCF on the goblet cell area observed 218 
in the current study agree with this suggestion in that goblet cell area increased with increased 219 
supplementation level, but it is also possible that NCF is having a direct effect on mucin production 220 
and subsequently increasing Bifidobacteria due to the increase in mucin production, as 221 
bifidobacteria can produce enzymes allowing them to utilise and proliferate on mucin glycoproteins 222 
(Katayama et al., 2005; Jung et al., 2008; Ruas-Madiedo et al., 2008).  223 
CONCLUSION  224 
Published research in this field appears to be highly variable, which may be due to differences in 225 
the type of MOS product, experimental conditions, diet formulation, or health status of the birds. 226 
This means that the mechanism of action of MOS and NCF and interactions with other nutritional 227 
and production  parameters are still not fully understood. In conclusion, under the conditions of 228 
this trial, NCF is having an positive effect on performance in the starter and grower phases 229 
indicating that the performance benefit of NCF could be age-dependent with younger birds 230 
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responding more than the older ones. Also, although there were no additional performance benefits 231 
to feeding NCF for a longer period, goblet cell area in the jejunum was increased, suggesting that 232 
birds fed NCF would have greater defences to pathogenic challenges due to higher levels of mucin. 233 
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Table 1. Composition of basal diet and calculated analysis of the basal diet 361 
Item  Starter Grower Finisher 
Ingredients (%)       
Barley 10.60 8.46 7.23 
Wheat 50.00 55.00 60.00 
Soya ext hipro 26.00 23.00 19.00 
Full fat soya bean meal 5.00 5.00 0.50 
 17 
 
L lysine HCL 0.31 0.26 0.25 
DL methionine 0.38 0.35 0.33 
L threonine 0.14 0.13 0.14 
Soya oil 4.00 4.50 4.75 
Limestone 1.25 1.25 1.25 
Monocalcium phosphate 1.50 1.25 1.25 
Salt 0.25 0.25 0.25 
Sodium bicarbonate 0.15 0.15 0.15 
Premix* 0.40 0.40 0.40 
Calculated analysis       
ME MJ/kg 12.80 13.00 13.20 
CP % 21.80 20.60 19.10 
Lys % 1.37 1.16 1.13 
Met + Cys % 1.01 0.95 0.89 
Ca 0.96 0.90 0.90 
Available P 0.73 0.66 0.65 
*Premix content (volume/kg diet): Mn 100mg, Zn 80mg, Fe 20mg, Cu 10mg, I 1mg, Mb 0.48mg, 362 
Se 0.2mg, Retinol 13.5mg,Cholecalciferol, 3mg, Tocopherol 25mg, Menadione 5.0mg, Thiamine 363 
3mg, Riboflavin 10.0mg, Pantothenic acid 15mg, Pyroxidine 3.0mg, Niacin 60mg, Cobalamin 364 
30µg, Folic acid 1.5mg, Biotin 125mg 365 
 366 
 367 
 368 
 369 
Table 2. Effect of NCF in broiler diets on the average body weight (g/bird) and FCR 370 
Attribute Age Dietary treatment SEM P value 
  (days) Control NCF 200g/t NCF 400g/t NCF 800g/t     
Body wt  1 43.33   43.90   43.58   43.05   0.34 0.851 
 (g) 7 102.44   114.20   106.68   107.05   2.02 0.227 
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  14 216.99 A 302.66 B 249.85 AC 290.68 BC 8.15 0.000 
  21 524.63 A 741.19 B 599.76 AC 680.33 BC 20.42 0.000 
  28 1026.17 A 1380.77 B 1198.38 AB 1287.23 B 31.17 0.000 
  35 1804.11 A 2179.73 B 1943.19 AC 2112.13 BC 36.98 0.001 
  42 2593.70 A 2927.65 B 2654.53 A 2841.69 AB 38.69 0.005 
FCR 0-14 2.03 A 1.59 B 1.91 AB 1.61 B 0.05 0.003 
  15-28 1.85 A 1.61 B 1.63 B 1.63 B 0.03 0.011 
  29-42 1.76   1.81   1.84   1.82   0.02 0.524 
  0-42 1.80   1.73   1.76   1.74   0.01 0.308 
(Differing superscript within one week denote means are significantly different at P ≤ 0.05) 371 
 372 
 373 
 374 
 375 
 376 
 377 
 378 
 379 
Table 3. Effect of NCF on the gut morphology of the duodenum and jejunum (± s.e) 380 
Attribute Control NCF 200g/t NCF 400g/t NCF 800g/t SEM P value 
Duodenum             
Villus Height 2819 2791 2891 2704 52.6 0.682 
 19 
 
Villus Width 274 265 262 282 5.5 0.575 
Crypt Depth 209 209 210 213 5.6 0.995 
Villus/Crypt Ratio 15.1 13.6 14.2 12.7 0.47 0.361 
Jejunum             
Villus Height 1284 1285 1379 1315 25.5 0.528 
Villus Width 247 235 223 249 5.5 0.351 
Crypt Depth 163 151 152 153 2.4 0.304 
Villus/Crypt Ratio 8.1 8.6 8.9 8.4 0.17 0.466 
 381 
 382 
 383 
 384 
 385 
 386 
 387 
 388 
 389 
 390 
 391 
Table 4. Effect of NCF on the goblet cell of the duodenum and jejunum(± s.e) 392 
Attribute             
Duodenum Control NCF 200g/t NCF 400g/t NCF 800g/t SEM P value 
 20 
 
GC Area (µm2) 59.2 69.4 58.3 62.6 2.5 0.263 
No of GC per 165µm 11.8 11.4 11.7 11.9 0.2 0.860 
GC Area per 165µm 683.1 747.0 664.4 719.3 23.6 0.314 
Jejunum   
 
          
GC Area (µm2) 67.6B 68.3B 73.8AB 82.8A 2.2 0.041 
No of GC per 165µm 12.4 12.2 12.0 11.8 0.2 0.741 
GC Area per 165µm 847.0 868.0 882.1 988.4 21.9 0.089 
(Differing superscript within one week denote means are significantly different at P ≤ 0.05) 393 
